Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment

NCT00824083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 950

Last updated 2016-04-28

No results posted yet for this study

Summary

The purpose of the study is to assess the functional outcome, quality of life and late sequelae in a representative sample of 600 long-term survivors of Ewing sarcoma and to build a unique clinical and functional data pool of the underlying cohort of 3000 Ewing sarcoma patients with a follow-up of 3 decades.

Conditions

  • Sarcoma, Ewing's

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV
  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Andreas Ranft, Dr. · University Hospital Muenster

  • Heribert Jürgens, Prof. · University Hospital Muenster

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824083 on ClinicalTrials.gov